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Convulsions and hyperglycaemia associated with nalidixic acid
Hyperglycaemia and convulsions in patients taking nalidixic acid are usually associated with overdosage of the drug or an underlying epileptic tendency.' :1 Nalidixic acid may also interfere with biochemical determinations of plasma and urinary glucose, giving falsepositive results. We describe an otherwise healthy patient who had convulsions and hyperglycaemia (confirmed by a glucose-specific method4) while on a therapeutic dose of the drug.
Case report
A 31-year-old housewife wakened 30 minutes after falling asleep, feeling giddy and complaining of a headache and a buzzing noise in her head. Soon afterwards she developed generalised jerking of her limbs, which was subsequently clearly described by her husband, although she had no recollection of these events. Over the next 45 minutes she had recurrent convulsions, and between attacks was unresponsive, although mumbling incoherently and sweating profusely. She was not incontinent and did not bite her tongue. Two days before she had been started on a course of nalidixic acid (Negram), 1 g four times daily, for urinary frequency and dysuria. Apart from oral contraceptives (Ovulen 50), which she had been taking for over a year, she was not taking any drugs. There was no history of alcohol intake, no evidence of drug overdose, and no family history of diabetes mellitus or epilepsy.
She looked unwell, pale, and tired, but no abnormality was found in any system, and neurological examination in particular gave normal results. Urine analysis (Labstix) showed ketonuria V , proteinuria , and glycosuria . Clinitest detected the presence of Io" reducing substances.
Blood glucose on admission was 10 8 mmol/I (195 mg, 100 ml), urea 5 mmol/1 (30 mg 100 ml), sodium 136 mmol(mEq),l, potassium 3-7 mmol(mEq)/l, and total CO2 24 mmol/1 (11 ml'100 ml). The white cell count was raised at 143 1091, (14 300 mm:), including 81°,) neutrophils, but other haematological values were normal. Urine cultures were sterile, and an intravenous pyelogram and creatinine clearance test showed nothing abnormal. A standard 50-g oral glucose tolerance test carried out four days later also gave a normal result. Drug treatment was discontinued after admission, and she made an uneventful recovery. An electroencephalogram on the day of admission showed minor non-specific bilateral episodic abnormalities, but further recordings taken five days and three months later were both within normal limits. A computerised brain scan (EMI) also showed no abnormality. After discharge she had no further convulsions.
Comment
Between 1964 and 1975 eight episodes of convulsions associated with nalidixic acid were reported to the Committee on Safety of Medicines,' and to 1971 three examples had been reported in Australia.' Standard pharmacological textbooks, however, record this side effect only in patients with conditions such as Parkinsonism, cerebrovascular insufficiency, or pre-existing epilepsy. Other reports associate convulsions with high or excessive doses only.
Islam and Sreedharan; reported convulsions, hyperglycaemia, and glycosuria due to nalidixic acid, but their patient was a 14-year-old girl who had taken an overdose of 6 5 g of the drug. Klumpp5, observed that the hyperglycaemia and glycosuria could both be false-positive results, since glucuronides of nalidixic acid present in urine can produce free glucuronic acid which acts as a reducing agent. In our patient, however, the method used to detect glycosuria (Labstix), and the assay that confirmed hyperglycaemia were specific for glucose. 4 We found no evidence of any epileptic tendency or underlying cerebral dysfunction in our patient, and conclude that even normal doses of nalidixic acid may cause convulsions in perfectly healthy people, probably as an idiosyncratic adverse reaction.
We thank Dr D A Seaton for permission to report this case. SHORT REPORTS Alpha and beta coma in drug intoxication
The electroencephalogram (EEG) has long been used in evaluating the comatose patient. The finding of alpha activity in the EEG insome patients in coma has aroused increasing interest, this being a pattern normally associated with wakefulness.' 2 This seemingly paradoxical combination of behavioural and electroencephalographic features has been termed "alpha coma" and has been seen mainly in cases of pontomesencephalic infarction or diffuse posthypoxic cerebral cortical necrosis. With few exceptions the prognosis in such cases has been dismal.:' Little has been published on alpha coma occurring in drug intoxication. We have recently seen four patients who were rendered comatose or stuporous by overdoses of nitrazepam or chlormethiazole in whom the EEG was dominated by frequencies in the alpha or slow beta range. Each made a complete recovery without neurological sequelae.
Patients and results
A 41-year-old man was rendered comatose by an overdose of nitrazepam. Corneal, gag, and ocular motor reflexes were absent on admission, but pupillary responses were preserved. There was generalised hyporeflexia and hypotonia, and plantar responses could not be elicited. The EEG on admission comprised generalised 10 Hz alpha activity, which was most prominent in the frontal and central regions. This activity did not attenuate with the application of painful, auditory, or visual stimuli. Gradually deepening respiratory depression without appreciable hypoxaemia prompted ventilatory assistance, which was continued for the next 36 hours without further sedation. During this period, together with recovery of brainstem
